Genomic Health - Articles and news items

Big data reconfirms accuracy of Oncotype DX breast cancer test

Industry news / 17 December 2015 / Victoria White

Genomic Health has announced results from multiple Oncotype DX breast cancer test studies that reconfirm the Oncotype DX test accurately predicts clinical outcomes in patients with early-stage invasive breast cancer…

Oncotype DX test predicts chemotherapy benefit in early-stage breast cancer

Industry news / 29 September 2015 / Victoria White

The Oncoptye DX test could prevent patients from the side effects of unnecessary chemotherapy treatment, and save NHS England up to £5 million per year…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+